Tiziana Life Sciences plc (NASDAQ: TLSA) (AIM: TILS) is a UK biotechnology company that focuses on the discovery and development of molecules to treat human disease in oncology and immunology, according to the company’s website (see here: www.tizianalifesciences.com). SNNLive spoke with Kunwar Shailubhai, CEO & CSO of Tiziana Life Sciences plc at the LD Micro Invitational 2019 in Bel Air, CA, and they discuss the following topics:
- Overview and history of Tiziana Life Sciences plc
- What makes Tiziana different and unique
- Clinical development
- Mr. Shailubhai’s background
- Growth drivers for 2019
For more information about Tiziana Life Sciences, please visit: www.tizianalifesciences.com
The interview may contain forward-looking statements about Tiziana Life Sciences plc. See Tiziana Life Sciences plc's periodic filings with Securities and Exchange Commission for more complete information.
Please read our full disclosure here.